1999 to Mid-2000s Saw Increase in Seniors Using Prescription Meds
By Elana Gotkine HealthDay Reporter
TUESDAY, July 9, 2024 -- From 1999 to the mid-2000s, the proportion of U.S. adults aged 65 years or older who used prescription medications increased, according to a research letter published online July 1 in JAMA Internal Medicine.
Gabriel K. Innes, V.M.D., Ph.D., from the U.S. Food and Drug Administration in Silver Spring, Maryland, and colleagues analyzed data from the National Health and Nutrition Examination Surveys to examine trends in prescription medication use and the top 10 most-used medication classes among adults aged 65 years or older during January 1999 to March 2020. Medication information was available for 14,917 participants aged 65 years and older.
The researchers found that any medication use increased from 83.9 to 90.0 percent during 1999 to 2000 through 2005 to 2006. There was an increase in the mean number of medications used per person, from 3.0 in 1999 to 2000 to 3.9 in 2004 to 2005 and to 4.3 in 2017 to March 2020. From 1999-2000 to 2003-2004, polypharmacy increased from 23.6 to 35.9 percent, peaking at 43.0 percent in 2017 to March 2020. Hyperpolypharmcy increased from 1.8 to 6.1 percent during 1999 to 2000 through 2007 to 2008. Potentially inappropriate medication (PIM) use decreased from 48.8 to 44.6 percent during the study period. Five of the top 10 most-used level 1 medication classes increased over time: cardiovascular, coagulation, gastrointestinal, metabolic, and psychotherapeutic agents.
"Understanding medication patterns can inform prescribing practices to reduce adverse drug events risk and unnecessary polypharmacy, hyperpolypharmacy, and PIMs," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-10 03:15
Read more
- Common Cold Symptoms
- Should You Stick with One Skin Care Brand?
- Bleeding During Pregnancy
- 10 Easy Ways to Use Beans
- The 8 Best Breathing Techniques for Sleep
- Vaccines for Children Program Has Increased Coverage, but Gaps Remain
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions